The Venture Codex Logo

The Venture Codex

Novartis Institutes for Biomedical Research

Fabrikstrasse 2, Novartis Campus, Basel, Basel-Stadt, CH-4056, Switzerland

Overview

Innovation engine for biomedical research and drug development.

Founded

1996

Deals ยท 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

Biotechnology
Medical
Robotics

Investment portfolio

8rounds
NAMEDATESIZE
Orna Therapeutics
Feb 2021Participated
$80 MSeries A
Cadent Therapeutics
Apr 2020Participated
$15 MSeries B
TScan Therapeutics
Jan 2020Participated
$60 MSeries B
Vor Biopharma
Feb 2019Participated
$42 MSeries A
Cadent Therapeutics
Nov 2018Participated
$40 MSeries B
Blade Therapeutics
Jun 2016Participated
$45 MSeries B
IDEAYA Biosciences
May 2016Participated
$46 MSeries A
Surface Oncology
Jan 2015Participated
$35 MSeries A
Orna Therapeutics
Feb 2021Participated
$80 MSeries A
Cadent Therapeutics
Apr 2020Participated
$15 MSeries B
TScan Therapeutics
Jan 2020Participated
$60 MSeries B
Vor Biopharma
Feb 2019Participated
$42 MSeries A
Cadent Therapeutics
Nov 2018Participated
$40 MSeries B
Blade Therapeutics
Jun 2016Participated
$45 MSeries B
IDEAYA Biosciences
May 2016Participated
$46 MSeries A
Surface Oncology
Jan 2015Participated
$35 MSeries A
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Novartis Institutes for Biomedical Research: 8 funding rounds are recorded in the selected participation categories.All available history.
Novartis Institutes for Biomedical Research: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A04
Series B04

Monthly Deal Activity

Novartis Institutes for Biomedical Research: 8 deals are recorded across 142 months.All available history.
Novartis Institutes for Biomedical Research: 8 deals are recorded across 142 months. All available history
MonthDeals
Jan '151
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '160
Feb '160
Mar '160
Apr '160
May '161
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '180
Nov '181
Dec '180
Jan '190
Feb '191
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '201
Feb '200
Mar '200
Apr '201
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '211
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Novartis Institutes for Biomedical Research: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Novartis Institutes for Biomedical Research: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8

Deal Size Distribution

Novartis Institutes for Biomedical Research: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Novartis Institutes for Biomedical Research: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M5
$50M-$100M2
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Novartis Institutes for Biomedical Research: United States has the largest recorded deal count among the displayed regions (8 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Novartis Institutes for Biomedical Research: United States has the largest recorded deal count among the displayed regions (8 deals). All available history
RegionDeals
United States8
Novartis Institutes for Biomedical Research: 20 co-investors are shown, with Atlas Venture sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Novartis Institutes for Biomedical Research: 20 co-investors are shown, with Atlas Venture sharing 3 recorded deals. All available history
Co-investorShared deals
Atlas Venture3
5AM Ventures2
Access Industries2
Astellas Venture Management2
Bristol Myers Squibb2
Clal Biotechnology Industries2
Cowen Healthcare Investments2
MPM Capital2
Osage University Partners2
Qiming Venture Partners2
6 Dimensions Capital1
Alexandria Venture Investments1
Amgen Ventures1
Bessemer Venture Partners1
Canaan Partners1
Celgene1
Deerfield Management1
dRx Capital1
F-Prime Capital1
F2 Ventures1

Investment Strategy

Novartis Institutes for Biomedical Research: Led accounts for 0% and participating for 100% of round participation.All available history.
Novartis Institutes for Biomedical Research: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating8100%
Novartis Institutes for Biomedical Research: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
Novartis Institutes for Biomedical Research: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Ann Richardson

CEO

Elise Burmeister Getz

Director, Translational Medicine

Elizabeth Mazsa

CS&I Academy Fellow

Jason Laramie

Title Vice President, Global Head Translational Medicine Data Science

Philip Gotwals

Global Head, Business Development & Licensing

Ross Jones

Lead of Product Excellence & Head of Product Operations

Thomas Jostock

Associate Director

Wendi Yajnik

Global Head of Academic Partnerships and External Innovation